• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N6-甲基腺苷修饰 ANLN 增强肝癌骨转移

N-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis.

机构信息

Third Department of Hepatic Surgery, Third Affiliated Hospital, Naval Medical University, Shanghai 200438, China.

Key Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer (SMMU), Ministry of Education, Shanghai 200438, China.

出版信息

Int J Biol Sci. 2023 Jan 22;19(4):1009-1023. doi: 10.7150/ijbs.73570. eCollection 2023.

DOI:10.7150/ijbs.73570
PMID:36923927
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10008695/
Abstract

Bones are categorized as the second most prevalent location of extra-hepatic metastasis in Hepatocellular Carcinoma (HCC), which is linked to an extremely poor prognosis due to limited therapeutic options. N-methyladenosine (mA) is a prominent modification involved in HCC, but the exact mechanisms on how mA modifications induce HCC bone metastases (BM) remain unclear. The key modulators responsible for the abundant mA RNA modification-induced HCC BM was found to be the and . The expression of Anillin actin-binding protein () was dramatically higher in HCC with BM tissues, and its messenger RNA (mRNA) stability was enhanced via mA epitranscriptomic regulation by and . High and expression along with nuclear protein was clinically correlated with BM in HCC patients. Furthermore, HCC BM was attributed to over-expression of nuclear forming a transcriptional complex with which enhanced transcriptional activity to activate the mTORC1 pathway, therefore increased the expression of and disproportionated expression in bone microenvironment leading to malignant neoplasms invade bone tissue. In addition, inhibition of mA modification by DZNeP attenuated HCC BM. This data provides meaningful understanding of the modulation and association of mA epitranscriptomic-regulated BM in HCC, and moreover, defines potentially valuable therapeutic targets.

摘要

骨骼是肝癌(HCC)肝外转移的第二大常见部位,由于治疗选择有限,预后极差。N6-甲基腺苷(m6A)是 HCC 中一种重要的修饰物,但 mA 修饰如何诱导 HCC 骨转移(BM)的确切机制尚不清楚。研究发现, 和 是导致富含 mA RNA 修饰诱导 HCC BM 的关键调节剂。在有 BM 组织的 HCC 中,Anillin 肌动蛋白结合蛋白( )的表达显著升高,其信使 RNA(mRNA)稳定性通过 和 对 mA 转录后修饰的调节得到增强。高 和 表达以及核 蛋白与 HCC 患者的 BM 具有临床相关性。此外,HCC BM 归因于核 表达增加,与 形成转录复合物,增强 转录活性,激活 mTORC1 途径,从而增加 和 在骨微环境中的表达,导致恶性肿瘤侵犯骨组织。此外,通过 DZNeP 抑制 mA 修饰可减轻 HCC BM。这些数据为理解 mA 转录后修饰调控 HCC BM 提供了有意义的认识,并确定了潜在有价值的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b77/10008695/3a070377aa76/ijbsv19p1009g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b77/10008695/ad9f2393dc81/ijbsv19p1009g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b77/10008695/e0027af7a7d3/ijbsv19p1009g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b77/10008695/c2d836d413c5/ijbsv19p1009g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b77/10008695/0b8eae10d1c3/ijbsv19p1009g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b77/10008695/9bc33fd212ce/ijbsv19p1009g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b77/10008695/5dce96c34fe8/ijbsv19p1009g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b77/10008695/3a070377aa76/ijbsv19p1009g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b77/10008695/ad9f2393dc81/ijbsv19p1009g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b77/10008695/e0027af7a7d3/ijbsv19p1009g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b77/10008695/c2d836d413c5/ijbsv19p1009g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b77/10008695/0b8eae10d1c3/ijbsv19p1009g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b77/10008695/9bc33fd212ce/ijbsv19p1009g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b77/10008695/5dce96c34fe8/ijbsv19p1009g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b77/10008695/3a070377aa76/ijbsv19p1009g007.jpg

相似文献

1
N-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis.N6-甲基腺苷修饰 ANLN 增强肝癌骨转移
Int J Biol Sci. 2023 Jan 22;19(4):1009-1023. doi: 10.7150/ijbs.73570. eCollection 2023.
2
RNA m A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy.RNA mA 甲基化通过 FOXO3 介导的自噬调节肝癌对索拉非尼的耐药性。
EMBO J. 2020 Jun 17;39(12):e103181. doi: 10.15252/embj.2019103181. Epub 2020 May 5.
3
METTL3 and METTL14-mediated N-methyladenosine modification of SREBF2-AS1 facilitates hepatocellular carcinoma progression and sorafenib resistance through DNA demethylation of SREBF2.METTL3 和 METTL14 介导的 SREBF2-AS1 的 N6-甲基腺苷修饰通过 SREBF2 的 DNA 去甲基化促进肝细胞癌进展和索拉非尼耐药。
Sci Rep. 2024 Mar 14;14(1):6155. doi: 10.1038/s41598-024-55932-7.
4
HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.HBXIP 通过 METTL3 介导的 HIF-1α m6A 修饰驱动肝癌细胞的代谢重编程。
J Cell Physiol. 2021 May;236(5):3863-3880. doi: 10.1002/jcp.30128. Epub 2020 Dec 11.
5
METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma.METTL3 通过 YTHDF1 促进 RBM14 的 m6A 超甲基化,从而促进肝癌的进展。
Hum Cell. 2022 Nov;35(6):1838-1855. doi: 10.1007/s13577-022-00769-3. Epub 2022 Sep 10.
6
Multiple mA RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis.多种 mA RNA 甲基化调节剂促进肝癌的恶性进展并影响其临床预后。
BMC Cancer. 2020 Feb 28;20(1):165. doi: 10.1186/s12885-020-6638-5.
7
Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6-Methyladenosine mRNA Methylation-Dependent Mechanism.射频消融不足通过N6-甲基腺苷mRNA甲基化依赖性机制促进肝细胞癌转移
Hepatology. 2021 Sep;74(3):1339-1356. doi: 10.1002/hep.31766.
8
SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma.SUMO1 修饰的甲基转移酶样蛋白 3 通过调节肝细胞癌中 Snail mRNA 的动态平衡促进肿瘤进展。
Theranostics. 2020 Apr 27;10(13):5671-5686. doi: 10.7150/thno.42539. eCollection 2020.
9
Anillin is required for tumor growth and regulated by miR-15a/miR-16-1 in HBV-related hepatocellular carcinoma.在乙肝相关肝细胞癌中,膜收缩蛋白对于肿瘤生长是必需的,且受miR-15a/miR-16-1调控。
Aging (Albany NY). 2018 Aug 9;10(8):1884-1901. doi: 10.18632/aging.101510.
10
An Alternatively Spliced Variant of METTL3 Mediates Tumor Suppression in Hepatocellular Carcinoma.METTL3 的一种可变剪接变体在肝细胞癌中发挥肿瘤抑制作用。
Genes (Basel). 2022 Apr 11;13(4):669. doi: 10.3390/genes13040669.

引用本文的文献

1
Stratification of Hepatocellular Carcinoma Using -Methyladenosine.使用N6-甲基腺苷对肝细胞癌进行分层
Cancers (Basel). 2025 Jul 2;17(13):2220. doi: 10.3390/cancers17132220.
2
From bone marrow mesenchymal stem cells to diseases: the crucial role of mA methylation in orthopedics.从骨髓间充质干细胞到疾病:甲基化在骨科中的关键作用
Stem Cell Res Ther. 2025 May 6;16(1):228. doi: 10.1186/s13287-025-04364-9.
3
m6A-induced DEAD-box RNA helicase 21 enhances lipid metabolism via 3‑hydroxy-3-methylglutaryl-CoA synthases 1 in colorectal cancer.

本文引用的文献

1
N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.N6-甲基腺苷 RNA 修饰在肿瘤免疫微环境中的作用:免疫治疗的新意义。
Front Immunol. 2021 Dec 9;12:773570. doi: 10.3389/fimmu.2021.773570. eCollection 2021.
2
Role of RANKL in cancer development and metastasis.RANKL 在癌症发展和转移中的作用。
J Bone Miner Metab. 2021 Jan;39(1):71-81. doi: 10.1007/s00774-020-01182-2. Epub 2021 Jan 2.
3
Anillin is a prognostic factor and is correlated with genovariation in pancreatic cancer based on databases analysis.
m6A诱导的DEAD盒RNA解旋酶21通过3-羟基-3-甲基戊二酰辅酶A合酶1增强结直肠癌中的脂质代谢。
Transl Oncol. 2025 May;55:102373. doi: 10.1016/j.tranon.2025.102373. Epub 2025 Mar 23.
4
MicroRNAs and RNA-Binding Protein-Based Regulation of Bone Metastasis from Hepatobiliary Cancers and Potential Therapeutic Strategies.基于微小RNA和RNA结合蛋白的肝胆癌骨转移调控及潜在治疗策略
Cells. 2024 Nov 21;13(23):1935. doi: 10.3390/cells13231935.
5
POU4F1 enhances lung cancer gemcitabine resistance by regulating METTL3-dependent TWF1 mRNA N6 adenosine methylation.POU4F1通过调节METTL3依赖的TWF1 mRNA N6腺苷甲基化增强肺癌吉西他滨耐药性。
3 Biotech. 2025 Jan;15(1):7. doi: 10.1007/s13205-024-04161-w. Epub 2024 Dec 12.
6
Emerging role of liver-bone axis in osteoporosis.肝-骨轴在骨质疏松症中的新作用
J Orthop Translat. 2024 Sep 4;48:217-231. doi: 10.1016/j.jot.2024.07.008. eCollection 2024 Sep.
7
Genetic variants of mA modification genes are associated with survival of HBV-related hepatocellular carcinoma.mA 修饰基因的遗传变异与 HBV 相关肝细胞癌的生存相关。
J Cell Mol Med. 2024 Aug;28(16):e18517. doi: 10.1111/jcmm.18517.
8
Alternative Splicing Landscape of Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌的可变剪接图谱
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241272051. doi: 10.1177/15330338241272051.
9
Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy.靶向 RNA 修饰的药物治疗:癌症治疗的新前沿。
Cancer Med. 2024 Apr;13(7):e6989. doi: 10.1002/cam4.6989.
10
Promotes the Proliferation and Migration of Gallbladder Cancer Cells via STRA6-Mediated Activation of PI3K/AKT Signaling.通过STRA6介导的PI3K/AKT信号激活促进胆囊癌细胞的增殖和迁移。
Cancers (Basel). 2024 Feb 11;16(4):752. doi: 10.3390/cancers16040752.
基于数据库分析,肌动蛋白结合蛋白是一种预后因素,且与胰腺癌的基因变异相关。
Oncol Lett. 2021 Feb;21(2):107. doi: 10.3892/ol.2020.12368. Epub 2020 Dec 10.
4
Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine.长链非编码 RNA NEAT1 通过 N6-甲基腺苷促进前列腺癌骨转移。
Mol Cancer. 2020 Dec 12;19(1):171. doi: 10.1186/s12943-020-01293-4.
5
Overloaded Orthopedic Force Induces Condylar Subchondral Bone Absorption by Stimulating Rat Mesenchymal Stem Cells Differentiating into Osteoclasts via mTOR-Regulated Secretion in Osteoblasts.过载矫形力通过 mTOR 调控的成骨细胞分泌作用诱导破骨细胞分化,从而导致髁状突软骨下骨吸收。
Stem Cells Dev. 2021 Jan 1;30(1):29-38. doi: 10.1089/scd.2020.0163. Epub 2020 Dec 15.
6
Overexpression of anillin is related to poor prognosis in patients with hepatocellular carcinoma.卷曲相关蛋白过表达与肝癌患者预后不良相关。
Hepatobiliary Pancreat Dis Int. 2021 Aug;20(4):337-344. doi: 10.1016/j.hbpd.2020.08.007. Epub 2020 Aug 31.
7
Anillin is an emerging regulator of tumorigenesis, acting as a cortical cytoskeletal scaffold and a nuclear modulator of cancer cell differentiation.肌球蛋白结合蛋白 Anillin 是一种新的肿瘤发生调节剂,作为皮质细胞骨架支架和癌细胞分化的核调节剂。
Cell Mol Life Sci. 2021 Jan;78(2):621-633. doi: 10.1007/s00018-020-03605-9. Epub 2020 Sep 3.
8
Molecular mechanisms and clinical management of cancer bone metastasis.癌症骨转移的分子机制与临床管理
Bone Res. 2020 Jul 29;8(1):30. doi: 10.1038/s41413-020-00105-1. eCollection 2020.
9
KIF2C: a novel link between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma.KIF2C:在肝细胞癌发病机制中 Wnt/β-连环蛋白和 mTORC1 信号之间的新联系。
Protein Cell. 2021 Oct;12(10):788-809. doi: 10.1007/s13238-020-00766-y. Epub 2020 Aug 3.
10
Anillin facilitates cell proliferation and induces tumor growth of hepatocellular carcinoma via miR-138/SOX4 axis regulation.锚蛋白通过miR-138/SOX4轴调控促进细胞增殖并诱导肝细胞癌肿瘤生长。
Transl Oncol. 2020 Oct;13(10):100815. doi: 10.1016/j.tranon.2020.100815. Epub 2020 Jul 6.